On Tuesday, Deutsche Bank adjusted its financial outlook for Ashland Inc . (NYSE:ASH), a company known for its specialty chemical solutions. The price target for Ashland's shares was lowered to $98.00 from the previous $100.00, but the firm maintained its Buy rating on the stock.
The revision reflects concerns over persistent weak industrial demand, particularly in Asia, and a more conservative stance on the recovery of industrial demand into 2025. Additionally, the potential negative impact of fixed cost absorption as production rates are adjusted to align with demand contributed to the reassessment.
The bank's analyst cited a reduction in fourth-quarter and full-year 2025 earnings estimates for Ashland by 5%, attributing most of the lowered expectations to the Specialty Additives segment due to its significant exposure to industrial markets.
Consequently, the fourth-quarter EBITDA forecast has been decreased by $7 million, or 5%, to $128 million, which is still a substantial 73% year-over-year increase but falls below the consensus estimate of $134 million. Similarly, the full-year 2025 EBITDA estimate has been reduced by $25 million, or 7%, to $510 million, representing a 10% year-over-year growth, against the consensus of $531 million.
Furthermore, the analyst has also trimmed the full-year 2026 EBITDA prediction by $35 million, or 6%, bringing it to $575 million, which would be a 13% increase year-over-year, aligning with the consensus figure.
Despite the headwinds facing the Specialty Additives segment and the added complexity to Ashland's outlook, Deutsche Bank remains optimistic about the company's prospects. The firm highlighted Ashland's strong positioning for technology-driven growth once underlying demand improves, as well as its robust balance sheet, which boasts a net debt to LTM EBITDA ratio of 2.3 times.
Ashland's valuation was also noted as attractive at 10.2 times the projected FY 2025 EBITDA, compared to the 13.8 times EBITDA for its peer Croda. The bank emphasized that each 1x EBITDA valuation difference equates to approximately $10 per share, or 12% of Ashland's current share price, reinforcing the rationale behind the Buy rating.
In other recent news, Ashland Inc. has made several key developments. The company reported steady third-quarter sales of $544 million, with a significant 22% increase in its Personal Care segment. However, demand in the Life Sciences segment softened. Ashland's financial position remains robust, with $399 million cash on hand and $1 billion in total liquidity.
The company also finalized the sale of its nutraceuticals division to an affiliate of Turnspire Capital Partners LLC, now known as Pharmachem Innovations. Additionally, Ashland revised the terms of its Receivables Purchase Agreement, reducing its accounts receivable securitization facility and extending its termination date.
InvestingPro Insights
In light of Deutsche Bank's recent financial outlook adjustment for Ashland Inc. (NYSE:ASH), it's worth considering additional metrics and insights from InvestingPro to provide a more comprehensive picture of the company's position. Ashland's management has demonstrated confidence in the company's value through aggressive share buybacks, underlining a proactive approach to capital allocation. Additionally, Ashland has not only raised its dividend for five consecutive years but has also maintained dividend payments for an impressive 54 years in a row, showcasing a strong commitment to shareholder returns.
InvestingPro data reveals a market capitalization of $4.23 billion and a Price to Earnings (P/E) ratio of 29.14, which adjusts to a more moderate 12.9 based on the last twelve months as of Q3 2024. Despite a revenue decline of 8.59% during the same period, Ashland maintains a healthy gross profit margin of 30.03%. Moreover, the company's dividend yield stands at 1.85%, coupled with a 5.19% growth in dividends, reflecting a tangible shareholder yield.
For investors seeking additional insights, InvestingPro offers more tips that delve into Ashland's financial health, including its strong free cash flow yield and its ability to cover short-term obligations with liquid assets. There are 9 additional InvestingPro Tips available, which can be accessed for a more in-depth analysis at https://www.investing.com/pro/ASH. These tips could provide investors with a nuanced understanding of Ashland's stability and potential for profitability in the current fiscal year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.